Minoxidil shedding: why it happens and when it stops

5 min read

Written by: 

Hannah Kaye

Reviewed by: 

Felix Gussone, MD

Published: Sep 20, 2022

Updated:  Jul 20, 2026

Trusted source badge

Reviewed By

Felix Gussone, MD

Felix Gussone, MD, is a physician and medical content specialist with over a decade of experience translating complex medical information into accessible, evidence-based content for the public.

View bio

Key takeaways

  • Minoxidil shedding is temporary hair fall that typically occurs in the first weeks of treatment, as the medication pushes older hairs out to make room for new growth.

  • The minoxidil shedding phase tends to last for up to two  weeks, according to the drug label, although studies have found that it can continue for 4–12 weeks.

  • A small 2025 study found that people who shed more at the start saw greater improvement in hair loss severity by week 24, but shedding does not prove that minoxidil is working and is not required for a response.

Here's what we'll cover

Here's what we'll cover

Key takeaways

  • Minoxidil shedding is temporary hair fall that typically occurs in the first weeks of treatment, as the medication pushes older hairs out to make room for new growth.

  • The minoxidil shedding phase tends to last for up to two  weeks, according to the drug label, although studies have found that it can continue for 4–12 weeks.

  • A small 2025 study found that people who shed more at the start saw greater improvement in hair loss severity by week 24, but shedding does not prove that minoxidil is working and is not required for a response.

If you've started using minoxidil for hair loss and noticed more hair falling out than usual, you're not alone, and it's typically not a reason to worry. 

Minoxidil shedding tends to happen because the drug shortens the resting phase of the hair cycle. It's temporary, usually lasting a few weeks to around three months, and may actually be a sign the treatment is working. Ahead, we explain why minoxidil shedding can happen, how long it lasts, and whether you can truly prevent it. 

Why does minoxidil cause shedding?

Minoxidil is thought to cause shedding by shortening the resting phase of the hair cycle. It's a vasodilator, which means it widens blood vessels and boosts blood flow to the scalp. That increased blood flow can help revive follicles that have stopped actively growing, pushing them back into a growth phase, although the precise mechanism is not fully understood. 

When many follicles make that transition at once, the old hairs they were holding on to fall out together. Not everyone will notice extra shedding, and for those who do, it's often short-lived.

In a small 2025 study, greater early shedding among those using 5% minoxidil was linked to greater improvements in hair density and other hair measurements at week 24. This suggests the drug is actively resetting the hair cycle. However, shedding is not required for minoxidil to work, and it does not guarantee that someone will respond to treatment.

Hair loss

Slow hair loss or even regain hair growth with dermatologist-selected treatments

How does the hair growth cycle work?

Hair moves through four phases in its growth cycle

  1. Growth (anagen)

  2. Transition (catagen)

  3. Rest (telogen)

  4. Shedding (exogen).

Each hair on your scalp is at a different stage at any given time. On a healthy scalp, about 9% of hairs are resting, and it's normal to lose up to 50–100 hairs per day.

In people with androgenetic alopecia (male and female pattern baldness), more hair follicles enter the resting phase, and the growth phase gets progressively shorter. This means hair spends less time actively growing and more time sitting idle.

In animal studies, topical minoxidil cut the resting phase from 20 days down to just 1–2 days, but this cannot establish the exact effect or timing in humans.

When many resting hairs re-enter growth at once, the old hairs fall out together. That return to growth is what produces a noticeable burst of shedding early on.

When does minoxidil shedding start and stop?

Extra shedding typically starts within the first 2–4 weeks of starting minoxidil. US labeling for 2% and 5% topical minoxidil says hair loss may temporarily increase or continue for up to two weeks after treatment begins.

However, clinical studies have observed longer shedding periods. A 2025 study found that the temporary increase in shedding associated with topical minoxidil generally lasted about two to six weeks.

Another small 2025 study tracking 49 people over 24 weeks found that shedding tends to peak around week four, then gradually tapers off by around week 12. 

That same small study found that shedding resolved sooner on average in participants using 5% minoxidil than in those using 2%. More research is needed to determine whether concentration consistently affects the duration of shedding. By week 16, daily hair fall had dropped significantly below pre-treatment levels, lower than before treatment even started. 

Greater early shedding was linked to better improvement in hair-loss severity at week 24 in this small study. However, it is not yet known whether shedding can reliably predict an individual person’s results.

Is minoxidil shedding a good sign?

Early minoxidil shedding is often a sign that the treatment is doing its job, even though more hair falling out can feel alarming. That’s because if minoxidil is pushing a large number of resting follicles back into the growth phase, more old hairs will fall out now, but more new hairs will replace them later. The bigger the reset, the more noticeable the shed.

Not everyone notices increased shedding, and researchers do not fully understand why it is more apparent in some people than others. Not shedding does not mean minoxidil will not work.

Does oral minoxidil cause shedding?

Yes, oral minoxidil, which is prescribed off-label for hair loss, can cause shedding, too.

In a study of 435 people with androgenetic alopecia on low-dose oral minoxidil (5 mg or less per day), 32% said they had more hair fall than usual. As with the topical form, this is thought to be short-lived and driven by the same process — follicles transitioning from rest into growth.

Some healthcare providers have patients continue topical minoxidil when switching to the oral form, to see if overlapping the two reduces initial shedding. However, a 2024 study found this approach didn't make much of a difference.

If you're thinking about starting or switching to oral minoxidil, it's worth talking to your healthcare provider about what to expect.

Can you prevent or reduce minoxidil shedding?

There's no sure way to stop minoxidil shedding from happening. Whether shedding occurs and how noticeable it is varies from person to person, and the factors that determine it are not fully understood. That said, a few things are worth knowing:

  • Strength matters: Minoxidil comes in 2% and 5%. Higher strengths may cause more side effects, including shedding, according to some studies. If the risk of extra shedding worries you, ask your provider about starting at a lower dose.  But keep in mind that there is no proven dose or concentration strategy for preventing initial shedding.

  • Don't stop suddenly: Minoxidil’s benefits generally last only while treatment continues. After topical minoxidil is stopped, regrown hair is usually lost over the next few months. If you want to stop, talk to your healthcare provider about a different hair loss treatment.

  • Think about pairing treatments: Some people use minoxidil with finasteride, which works by lowering DHT (the hormone behind androgenetic alopecia). Research suggests that combining the two topically may boost results. Ro offers Ro Mane Spray*, a topical combo that has both finasteride and minoxidil.

*Though this particular formulation is not approved by the US Food and Drug Administration (FDA), it is composed of active ingredients that have been individually FDA-approved for hair loss.

Other minoxidil side effects

Shedding isn't the only side effect linked to minoxidil. Other possible side effects from the topical form include:

  • Scalp itching

  • Flaking or irritated skin

  • Redness or burning on the scalp

  • Hypertrichosis (unwanted hair growth outside the scalp)

Oral minoxidil may also cause fluid retention and body hair growth. Oral minoxidil also carries an FDA boxed warning for heart-related risks. Low doses prescribed appear to carry a lower risk. 

Side effects from topical minoxidil are often limited to the scalp or nearby skin. Oral minoxidil can cause systemic effects and should be prescribed and monitored by a healthcare provider. Since side effects can vary from person to person, talk to your healthcare provider if something doesn't clear up or gets worse.

When to talk to a healthcare provider

Some shedding in the early weeks of minoxidil use is normal and tends to stop on its own. It's a good idea to reach out to a healthcare provider if you notice:

  • Shedding that is severe, continues to worsen, or does not begin improving over the following several weeks. (Product labeling advises contacting a healthcare provider if increased hair loss continues for more than two weeks)

  • Scalp irritation or redness that won’t clear up on its own

  • Sudden patchy bald spots, or any hair loss pattern that doesn't look like typical thinning

If minoxidil isn't giving you the results you want, a healthcare provider can help figure out the next step.

Hair loss

Get minoxidil in a convenient, once-a-day tablet if prescribed

Bottom line

Seeing more hair fall out after starting a hair loss treatment can feel scary, but minoxidil shedding is a normal, short-lived part of the process. A few things worth keeping in mind:

  • Don't stop using minoxidil just because you're shedding. The extra hair fall is an expected effect of the drug, not a reason to quit.

  • Minoxidil typically takes time to produce results. Most shedding settles within 4–12 weeks, and noticeable new growth typically appears by months 4–6.

  • Both topical and oral forms can cause shedding. There's no proven way to prevent it.

Talk to a healthcare provider if shedding is severe, worsening, patchy, accompanied by other symptoms, or does not begin to improve over the following weeks.

Frequently asked questions (FAQs)

DISCLAIMER

If you have any medical questions or concerns, please talk to your healthcare provider. The articles on Health Guide are underpinned by peer-reviewed research and information drawn from medical societies and governmental agencies. However, they are not a substitute for professional medical advice, diagnosis, or treatment.

Oral Minoxidil Important Safety Information: Read more about serious warnings and safety info.

Finasteride Important Safety Information: Read more about serious warnings and safety info.

References

  • Bi, L., Kan, H., Wang, J., et al. (2025). Whether the transient hair shedding phase exist after minoxidil treatment and does it predict treatment efficacy? A retrospective study in androgenetic alopecia patients. Journal of Dermatological Treatment, 36(1), 2480739. doi: 10.1080/09546634.2025.2480739. Retrieved from https://pubmed.ncbi.nlm.nih.gov/40122142/

  • Ho, C. H., Sood, T., & Zito, P. M. (2024). Androgenetic alopecia. StatPearls. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK430924/

  • Hussein, R. S., Bin Dayel, S., Abahussein, O., et al. (2024). Applications and efficacy of minoxidil in dermatology. Skin Health and Disease, 4(6), e472. doi: 10.1002/ski2.472. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC11608877/

  • Li, X., Wang, X., Wang, C., et al. (2022). Hair shedding evaluation for alopecia: A refined wash test. Clinical, Cosmetic and Investigational Dermatology, 15, 117–126. doi: 10.2147/CCID.S347898. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC8801509/

  • Li, Y., Huang, Q., Zhou, Z., et al. (2025). Comparing minoxidil-finasteride mixed solution with minoxidil solution alone for male androgenetic alopecia: a systematic review and meta-analysis of randomized controlled trials. Frontiers in Medicine, 12, 1632139. doi: 10.3389/fmed.2025.1632139. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC12537375/

  • Mori, O. & Uno, H. (1990). The effect of topical minoxidil on hair follicular cycles of rats. Journal of Dermatology, 17(5), 276–281. doi: 10.1111/j.1346-8138.1990.tb01641.x. Retrieved from https://pubmed.ncbi.nlm.nih.gov/2380431/

  • Natarelli, N., Gahoonia, N., & Sivamani, R. K. (2023). Integrative and mechanistic approach to the hair growth cycle and hair loss. Journal of Clinical Medicine, 12(3), 893. doi: 10.3390/jcm12030893. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC9917549/

  • Nohria, A., Desai, D., Sikora, M., et al. (2024). Combating "dread shed": The impact of overlapping topical and oral minoxidil on temporary hair shedding during oral minoxidil initiation. JAAD International, 15, 220–224. doi: 10.1016/j.jdin.2024.03.005. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC11067493/

  • Patel, P., Nessel, T. A., & Kumar, D. D. (2023). Minoxidil. StatPearls. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK482378/

  • Sanabria, B., de Nardo Vanzela, T., Miot, H. A., et al. (2021). Adverse effects of low-dose oral minoxidil for androgenetic alopecia in 435 patients. Journal of the American Academy of Dermatology, 84(4), 1175–1178. doi: 10.1016/j.jaad.2020.11.035. Retrieved from https://pubmed.ncbi.nlm.nih.gov/33253848/

  • Suchonwanit, P., Thammarucha, S., & Leerunyakul, K. (2019). Minoxidil and its use in hair disorders: A review. Drug Design, Development and Therapy, 13, 2777–2786. doi: 10.2147/DDDT.S214907. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC6691938/

  • U.S. Food and Drug Administration (FDA). (2015). Highlights of prescribing information: Loniten (minoxidil tablets). Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/018154s026lbl.pdf

  • U.S. Food and Drug Administration (FDA). (2021). Highlights of prescribing information: Propecia (finasteride) tablets. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020788s028lbl.pdf

  • U.S. Food and Drug Administration (FDA). (2015). Highlights of prescribing information: Rogaine Extra Strength for Men (minoxidil topical solution 5%). Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020834Orig1s014lbl.pdf

  • Zari, S. (2023). Compliance to topical minoxidil and reasons for discontinuation among patients with androgenetic alopecia. Dermatology and Therapy, 13(5), 1157–1169. doi: 10.1007/s13555-023-00919-x. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC10149432/

  • Zhang, Y., Wu, L., Zhao, W., et al. (2025). Monitoring and evaluation of temporary increase in hair shedding induced by topical minoxidil in androgenetic alopecia: A multicenter prospective cohort study. Journal of the American Academy of Dermatology, 93(6), 1602–1604. doi: 10.1016/j.jaad.2025.08.025. Retrieved from https://pubmed.ncbi.nlm.nih.gov/40835129/